These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17209267)

  • 1. Immunisation of refugee and migrant young people: can schools do the job?
    Milne B; Raman S; Thomas P; Shah S
    Aust N Z J Public Health; 2006 Dec; 30(6):526-8. PubMed ID: 17209267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refugee youth--immunisation status and GP attendance.
    Thomas P; Milne B; Raman S; Shah S
    Aust Fam Physician; 2007 Jul; 36(7):568-70. PubMed ID: 17619678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018.
    Mellou K; Silvestros C; Saranti-Papasaranti E; Koustenis A; Pavlopoulou ID; Georgakopoulou T; Botsi C; Terzidis A
    Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.
    Roberts RJ; Sandifer QD; Evans MR; Nolan-Farrell MZ; Davis PM
    BMJ; 1995 Jun; 310(6995):1629-32. PubMed ID: 7795447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
    Ogbuanu IU; Kutty PK; Hudson JM; Blog D; Abedi GR; Goodell S; Lawler J; McLean HQ; Pollock L; Rausch-Phung E; Schulte C; Valure B; Armstrong GL; Gallagher K
    Pediatrics; 2012 Dec; 130(6):e1567-74. PubMed ID: 23129075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisations among school leavers: is there a place for measles-mumps-rubella vaccine?
    Lashkari HP; El Bashir H
    Euro Surveill; 2010 Apr; 15(17):. PubMed ID: 20460082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination for tomorrow: the need to improve immunisation rates.
    Kassianos G
    J Fam Health Care; 2010; 20(1):13-6. PubMed ID: 20397551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better primary health care for refugees - catch up immunisation.
    Phillips CB; Benson J
    Aust Fam Physician; 2007 Jun; 36(6):440-2, 444. PubMed ID: 17565403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.
    Cardemil CV; Dahl RM; James L; Wannemuehler K; Gary HE; Shah M; Marin M; Riley J; Feikin DR; Patel M; Quinlisk P
    N Engl J Med; 2017 Sep; 377(10):947-956. PubMed ID: 28877026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a school entry law on adolescent immunization rates.
    Wilson TR; Fishbein DB; Ellis PA; Edlavitch SA
    J Adolesc Health; 2005 Dec; 37(6):511-6. PubMed ID: 16310129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000.
    Fogarty KJ; Massoudi MS; Gallo W; Averhoff FM; Yusuf H; Fishbein D
    Public Health Rep; 2004; 119(2):163-9. PubMed ID: 15192903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccination.
    Skinner SR; Imberger A; Nolan T; Lester R; Glover S; Bowes G
    Aust N Z J Public Health; 2000 Jun; 24(3):298-304. PubMed ID: 10937408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.
    Petrovic M; Roberts R; Ramsay M
    BMJ; 2001 Jan; 322(7278):82-85. PubMed ID: 11154622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to childhood immunisation services and its determinants among recent and settled migrants in Delhi, India.
    Kusuma YS; Kaushal S; Sundari AB; Babu BV
    Public Health; 2018 May; 158():135-143. PubMed ID: 29602525
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.